LIN vs TLSIW
Linde plc Ordinary Shares (LIN) versus TriSalus Life Sciences Inc. (TLSIW) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
TriSalus Life Sciences Inc. (TLSIW) common stock listed on NASDAQ.
Latest reported LIN revenue for 2026-06-30 was $18.07B. Net income was $3.79B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
TLSIW does not have a complete income-statement cache yet.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. TLSIW currently screens at market cap $0.
Not investment advice. Open the LIN and TLSIW stock pages for the full models.
Not investment advice.